Tigecycline for carbapenem-resistant Klebsiella pneumoniae infections in the intensive care unit

被引:30
作者
Vardakas, Konstantinos Z. [1 ,2 ]
Matthaiou, Dimitrios K. [3 ]
Falagas, Matthew E. [1 ,2 ,6 ]
Antypa, Elli [4 ]
Koteli, Asimoula [5 ]
Antoniadou, Eleni [4 ]
机构
[1] Alfa Inst Biomed Sci, Athens 15123, Greece
[2] Iaso Gen Hosp, Dept Internal Med Infect Dis, Athens, Greece
[3] Attikon Univ Hosp, Intens Care Unit, Athens, Greece
[4] Genimatas Gen Hosp, Intens Care Unit, Thessaloniki, Greece
[5] Agios Pavlos Gen Hosp, Dept Microbiol, Thessaloniki, Greece
[6] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA
关键词
REGIMENS;
D O I
10.3109/23744235.2015.1049659
中图分类号
R51 [传染病];
学科分类号
100201 [内科学];
摘要
引用
收藏
页码:751 / 753
页数:3
相关论文
共 9 条
[1]
[Anonymous], J INFECT
[2]
[Anonymous], SCAND J INFECT
[3]
Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI
[4]
Effectiveness and safety of high-dose tigecycline-containing regimens for the treatment of severe bacterial infections [J].
Falagas, Matthew E. ;
Vardakas, Konstantinos Z. ;
Tsiveriotis, Konstantinos P. ;
Triarides, Nikolaos A. ;
Tansarli, Giannoula S. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2014, 44 (01) :1-7
[5]
Antibiotic Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae: Systematic Evaluation of the Available Evidence [J].
Falagas, Matthew E. ;
Lourida, Panagiota ;
Poulikakos, Panagiotis ;
Rafailidis, Petros I. ;
Tansarli, Giannoula S. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (02) :654-663
[6]
FDA, 2009, TYG TIG INJ
[7]
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance [J].
Magiorakos, A. -P. ;
Srinivasan, A. ;
Carey, R. B. ;
Carmeli, Y. ;
Falagas, M. E. ;
Giske, C. G. ;
Harbarth, S. ;
Hindler, J. F. ;
Kahlmeter, G. ;
Olsson-Liljequist, B. ;
Paterson, D. L. ;
Rice, L. B. ;
Stelling, J. ;
Struelens, M. J. ;
Vatopoulos, A. ;
Weber, J. T. ;
Monnet, D. L. .
CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (03) :268-281
[8]
Randomized Phase 2 Trial To Evaluate the Clinical Efficacy of Two High-Dosage Tigecycline Regimens versus Imipenem-Cilastatin for Treatment of Hospital-Acquired Pneumonia [J].
Ramirez, Julio ;
Dartois, Nathalie ;
Gandjini, Hassan ;
Yan, Jean Li ;
Korth-Bradley, Joan ;
McGovern, Paul C. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (04) :1756-1762
[9]
Carbapenem-Sparing Antibiotic Regimens for Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Intensive Care Unit [J].
Sbrana, Francesco ;
Malacarne, Paolo ;
Viaggi, Bruno ;
Costanzo, Sergio ;
Leonetti, Piero ;
Leonildi, Alessandro ;
Casini, Beatrice ;
Tascini, Carlo ;
Menichetti, Francesco .
CLINICAL INFECTIOUS DISEASES, 2013, 56 (05) :697-703